MAJA MILOSLAVSKY, PH.D.

Loxo Oncology at Lily

Maja is currently Vice President, Biostatistics at Loxo Oncology at Lilly. Maja has worked in drug development throughout her 20 year career, across therapeutic areas and different organization types and sizes. She started her career as a study statistician at Alza, a Janssen Company, further developing her leadership, team and infrastructure building experience by starting a biometrics group at a small Japanese company Teikoku Pharma in the neurology space. Maja returned to Janssen for an opportunity to lead a statistics team in AD drug development and later joined Jazz Pharmaceuticals where over 7 years Maja served as the statistical lead for the oncology portfolio and later the department leader for biostatistics, statistical programming and medical writing and a member of the R&D leadership team. After an opportunity to once again contribute to the neurology space at Prothena Biosciences, Maja joined Loxo Oncology at Lilly with a focus on executive leadership, team development, and agile drug development in the oncology space. Maja is a pharma/biotech leader with a passion for problem solving, cross functional collaboration, and reading fiction. Maja received her PhD in Biostatistics from University of California Berkeley.